Insider · CIK 0001787176
John Dobak
Files at DMTK (DermTech, Inc.). First filing Mar 9, 2023, latest Apr 6, 2023.
In brief
John Dobak files SEC Form 4 as CEO and director at DMTK (DermTech, Inc.). Since Mar 9, 2023, John Dobak has reported 0 open-market buys worth $0 and 3 open-market sells worth $107k, the latest filed on Apr 6, 2023.
A track record needs three past buys with six months of prices behind them; John Dobak has 0, so none is measured yet.
The newest scored trade: sold $5,082 of DMTK on Mar 13, 2023, filed Apr 6, 2023, scored 40 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | DermTech, Inc. | $5,082 1,559 shares | -0% | - | |
| 40Moderate | DermTech, Inc. | $5,082 1,559 shares | -0% | - | |
| 50Moderate | DermTech, Inc. | $97k 23,955 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 13, 2023 | DMTK DermTech, Inc. | 20,000 0.07% of outstanding | $70k | Jul 13, 2023 | $38k |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | DMTK DermTech, Inc. | AGrant or award Common Stock | +56,407 | $0.00 | $0 | 700,252 | Apr 6, 2023 |
| Mar 13, 2023 | DMTK DermTech, Inc. | SOpen-market sale Common Stock | -1,559 | $3.26 | $5,082 | 698,693 | Apr 6, 2023 |
| Mar 9, 2023 | DMTK DermTech, Inc. | AGrant or award Common Stock | +56,407 | $0.00 | $0 | 700,252 | Mar 13, 2023 |
| Mar 13, 2023 | DMTK DermTech, Inc. | SOpen-market sale Common Stock | -1,559 | $3.26 | $5,082 | 698,693 | Mar 13, 2023 |
| Mar 7, 2023 | DMTK DermTech, Inc. | SOpen-market sale Common Stock | -709 | $4.06 | $2,879 | 667,091 | Mar 9, 2023 |
| Mar 7, 2023 | DMTK DermTech, Inc. | SOpen-market sale Common Stock | -23,246 | $4.06 | $94k | 643,845 | Mar 9, 2023 |
Questions about John Dobak
Answered from the filings on this page, as of the latest one.
Is John Dobak buying or selling?
Not in the last 12 months. John Dobak's latest open-market trade on SEC Form 4 was sold $5,082 of DMTK on Mar 13, 2023.
How did John Dobak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Dobak has 0.
Where does John Dobak file Form 4?
John Dobak has filed Form 4 at DMTK (DermTech, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.